With the aim of promoting and allowing young and talented researchers to do great science, IBSA Foundation for scientific research offers 7 fellowships of € 32.000 in the following research fields:
IBSA Foundation Research Equity Prize
As part of the IBSA Foundation Fellowships, a €5,000 award will be given to the best scientific project developed in a laboratory, research institute or university based in a developing country.
This special award aims to promote equity in access to research, recognising emerging scientific excellence in resource-limited contexts and strengthening international dialogue within the scientific community.
The list of eligible countries is available on the United Nations website: Africa, Latin America and the Caribbean, Asia excluding Israel, Japan and the Republic of Korea, and Oceania excluding Australia and New Zealand.
Application Procedure
Applicants are invited to submit their proposals no later than the 31st of January 2027 on the dedicated platform (https://ibsafoundation.poliresearch.com/) and shall provide the following additional documents as separate files:
Applications and supporting documentation are only accepted via the online application system.
Selection Process
Proposals are evaluated by the Scientific Board of IBSA Foundation through a peer review process. The Board will make its final decision after having considered the recommendations of the Board. Award decisions are final.
Applicants are promptly informed as soon as a decision is reached, normally within three months from the deadline. The award is assigned only after presentation of the acceptance letter by the Host Institution, which should be sent to the IBSA Foundation within one week of the communication.
The Awards Ceremony will be held in during spring 2027.
The exact date, venue and modality will be confirmed when the results are announced.
This is the primary evaluation criterion.
The Scientific Board explicitly assesses the quality of the proposed project based on:
Competitive proposals should present:
Innovation is a major component of project evaluation.
Competitive projects should demonstrate:
Projects that introduce genuinely new concepts or technologies are particularly competitive.
The Foundation explicitly evaluates feasibility.
Competitive applications include:
Even highly innovative projects must demonstrate that they can realistically be completed within the fellowship period.
The applicant's curriculum vitae is a formal evaluation criterion.
Reviewers consider:
Applicants should demonstrate a strong trajectory for future scientific leadership.
The suitability of the host institution is explicitly reviewed.
Competitive host laboratories provide:
A well-matched host institution increases confidence in successful project completion.
A distinctive feature of the IBSA Foundation is its encouragement of scientific mobility.
Applicants who:
receive a note of merit from the Scientific Board.
Competitive proposals should align with one of the Foundation's supported fields, including:
Projects closely aligned with these themes are more competitive.
The fellowship is specifically designed for young researchers.
Eligible applicants include:
Applicants must generally be under 40 years of age and actively engaged in biomedical research at a qualifying host institution.
Applicants are required to submit their best peer-reviewed publications.
Competitive candidates typically demonstrate:
While early-career applicants are expected, a solid publication record strengthens competitiveness.
The Foundation aims to support researchers who will become future scientific leaders.
Competitive proposals should demonstrate that the fellowship will:
Applicants of any nationality must be under 40 years old on the deadline for the submission of proposals.
They must have a degree in medicine, biology, pharmacy, biotechnology or bioengineering. Open to PhD students, PhD, Post-Doc and residents. Permanent positions such as Professors cannot apply.
For the entire duration of the grant, applicants must be active in the Host Institution, i.e. a research organization (such as universities, hospitals or other research centres), irrespective of its legal status (organized under public or private law), whose primary goal is to independently conduct non-economic biomedical research and to disseminate its results.
Sponsor Institute/Organizations: IBSA Foundation
Sponsor Type: Corporate/Non-Profit
Address: Casa Carlo Cattaneo, Strada di Gandria 4, 6976 Castagnola-Lugano
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jan 31, 2027
$5,754
€5,000
Affiliation: IBSA Foundation
Address: Casa Carlo Cattaneo, Strada di Gandria 4, 6976 Castagnola-Lugano
Website URL: https://ibsafoundation.poliresearch.com/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.